Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Shanghai City, China Clinical Trials

A listing of Shanghai City, China clinical trials actively recruiting patients volunteers.

Found (69) clinical trials

A Study on Whether Patients Prefer the Spiriva Respimat or the Spiriva Handihaler for Treating Their Chronic Obstructive Pulmonary Disease (COPD)

The objective of this study is to investigate the patient acceptability/preference of Respimat compared with Handihaler in patients with moderate to severe chronic obstructive pulmonary disease (COPD) to demonstrate the superiority of Respimat.

Phase

1.15 miles

Learn More »

Different Anti-Spastic Therapy Strategies After CABG Using Radial Artery Grafts

After having signed informed consent (Day 1-3), eligible subjects who have successfully received first RA-CABG surgery (Day 0) will be screened for enrollment. All subjects (about 100 patients) will be randomized in a 1:1:1 ratio into 3 groups. Group A will receive oral Nicorandil (5mg tid) monotherapy; Group B will …

Phase

1.15 miles

Learn More »

Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer

The purpose of this single arm study is to assess the safety and efficacy of ATAN (Apatinib) in patients with Chemo-refractory Advanced or Metastatic Adenocarcinoma of Stomach or Gastroesophageal Junction in clinical practice. ATAN will be given to patients who had failed at least two lines of prior chemotherapy. Eligible …

Phase

1.2 miles

Learn More »

Effect of Entecavir Treatment on Regression and Disease Outcome in HBV-induced Liver Fibrosis and Cirrhosis Patients

Patients who have completed 2-years entecavir-based treatment in Regress Study will receive another 5-years entecavir extension therapy. Patients will be assessed at baseline and every six months for blood cell count, liver function test, HBVDNA, AFP, prothrombin time, liver ultrasonography, and Fibroscan; A third liver biopsy will be performed at …

Phase

1.66 miles

Learn More »

Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients

To investigate whether sequential combination therapy with Thymosin alpha 1 and entecavir is superior to continuous ETV monotherapy in HBeAg-positive chronic hepatitis B patients with previous long-term entecavir therapy ( 1 years), and to select the optimal patients who may benefit from sequential combination therapy.

Phase

1.66 miles

Learn More »

Efficacy and Safety of TAF in Patients With Suboptimal Response to Other Nucleos(t)Ides

This is a prospective, single-arm, multicenter cohort study evaluating the efficacy, safety, and tolerability of TAF monotherapy in in Asian CHB adults with SOR to the nucleos(t)ide therapy by assessing the HBV DNA suppression in 48 weeks. Approximately one hundred adults who received the aforementioned nucleos(t)ide therapy will be prospectively …

Phase

1.66 miles

Learn More »

Protective Effects of Saxagliptin (And Vitamin D3) on Cell Function in Adult-onset Latent Autoimmune Diabetes

LADA is actually a form of type 1 diabetes, which is caused by autoimmune damage of islet cells and triggered by environmental factors based on genetic susceptibility. LADA shows some characteristics of type 2 diabetes at its onset, which develops slowly and latent, and easily be misdiagnosed as type 2 …

Phase

1.81 miles

Learn More »

Early Cognitive Function in Elderly Patients After Laser Laryngeal Surgery: Des vs Prop

The allocation sequence is generated by computer random number generation, and the allocation is placed in sequentially numbered opaque sealed envelopes by a non-investigator. Enrolment and data collection are performed by trained research staff who are not involved in the care of the patients. The treating clinicians are not blinded …

Phase

1.81 miles

Learn More »

Evaluation of OZURDEX in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China

This study will take place in China to evaluate the safety and efficacy of OZURDEX implant 700 g in the treatment of macular edema due to retinal vein occlusion (RVO) in patients who have never received treatment for RVO.

Phase

1.81 miles

Learn More »